Evidence map›Paper›PMID 36000850›Full record

ArticleJournal of virology2022

The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.

Mathias Martins, Gabriela M do Nascimento, Mohammed Nooruzzaman, Fangfeng Yuan, Chi Chen, Leonardo C Caserta, Andrew D Miller, Gary R Whittaker, Ying Fang, Diego G Diel

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. SARS-CoV-2 mutant spectrum complexity is an epidemiologically evolvable trait.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. Article
  7. Viruses · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Mathias MartinsDepartment of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell Universitygrid.5386.8, Ithaca, New York, USA.ORCID 0000-0002-8290-5756
Gabriela M do NascimentoDepartment of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell Universitygrid.5386.8, Ithaca, New York, USA.
Mohammed NooruzzamanDepartment of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell Universitygrid.5386.8, Ithaca, New York, USA.
Fangfeng YuanDepartment of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaigngrid.35403.31, Urbana, Illinois, USA.
Chi ChenDepartment of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaigngrid.35403.31, Urbana, Illinois, USA.
Leonardo C CasertaDepartment of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell Universitygrid.5386.8, Ithaca, New York, USA.
Andrew D MillerDepartment of Biomedical Sciences, Section of Anatomic Pathology, College of Veterinary Medicine, Cornell Universitygrid.5386.8, Ithaca, New York, USA.
Gary R WhittakerDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell Universitygrid.5386.8, Ithaca, New York, USA.
Ying FangDepartment of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaigngrid.35403.31, Urbana, Illinois, USA.
Diego G DielDepartment of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell Universitygrid.5386.8, Ithaca, New York, USA.ORCID 0000-0003-3237-8940
Cornell University · USUniversity of Illinois Urbana-Champaign · US

Funding

Novel diagnostic tools and animal model system for study human/animal interface of COVID-19R01AI166791 · NIAID · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI DIEL, DIEGO G, FANG, YING · 2021 to 2024
$3.1M
NIAID NIH HHS R01 AI166791
6 · The paper itself

Abstract

Omicron (B.1.1.529) is the most recent SARS-CoV-2 variant of concern, which emerged in late 2021 and rapidly achieved global predominance by early 2022. In this study, we compared the infection dynamics, tissue tropism, and pathogenesis and pathogenicity of SARS-CoV-2 D614G (B.1), Delta (B.1.617.2), and Omicron BA.1.1 (B.1.1.529) variants in a highly susceptible feline model of infection. Although D614G- and Delta-inoculated cats became lethargic and showed increased body temperatures between days 1 and 3 postinfection (pi), Omicron-inoculated cats remained subclinical and, similar to control animals, gained weight throughout the 14-day experimental period. Intranasal inoculation of cats with D614G- and the Delta variants resulted in high infectious virus shedding in nasal secretions (up to 6.3 log

Indexed as

SARS-CoV-2AnimalsCatsCOVID-19Disease Models, AnimalHumansVirulenceVirus ReplicationcatsCOVID-19DeltaOmicronpathogenesispathogenicitySARS-CoV-2variant of concern

Identifiers

PMID36000850
PMCPMC9472624
OpenAlexW4293212210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.